Addex Therapeutics Ltd. (ADXN) Non-Current Assets (2022 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Addex Therapeutics' Non-Current Assets history spans 3 years, with the latest figure at $8.1 million for Q4 2024.

• For Q4 2024, Non-Current Assets rose 1674.36% year-over-year to $8.1 million; the TTM value through Dec 2024 reached $8.1 million, up 1674.36%, while the annual FY2024 figure was $8.1 million, 1688.95% up from the prior year.
• Non-Current Assets for Q4 2024 was $8.1 million at Addex Therapeutics, up from $459148.9 in the prior quarter.
• Across five years, Non-Current Assets topped out at $8.1 million in Q4 2024 and bottomed at $459148.9 in Q4 2023.
• The 3-year median for Non-Current Assets is $470316.3 (2022), against an average of $3.0 million.
• The largest annual shift saw Non-Current Assets dropped 2.37% in 2023 before it soared 1674.36% in 2024.
• A 3-year view of Non-Current Assets shows it stood at $470316.3 in 2022, then fell by 2.37% to $459148.9 in 2023, then skyrocketed by 1674.36% to $8.1 million in 2024.
• Per Business Quant, the three most recent readings for ADXN's Non-Current Assets are $8.1 million (Q4 2024), $459148.9 (Q4 2023), and $470316.3 (Q4 2022).

Peer Comparison